During the past decade, New Hanover Regional Medical Center/Zimmer Cancer Center conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 21 clinical trials were completed, i.e. on average, 210% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 9 clinical trials were completed. i.e. 450% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New Hanover Regional Medical Center/Zimmer Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 23 trials, followed by "Gynecologic Oncology Group" with 5 trials sponsored, "National Cancer Institute (NCI)" with 5 trials sponsored, "Radiation Therapy Oncology Group" with 5 trials sponsored and "SWOG Cancer Research Network" with 5 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New Hanover Regional Medical Center/Zimmer Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "New Hanover Regional Medical Center/Zimmer Cancer Center" are "Breast Cancer" (10 trials), "Lung Cancer" (7 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (5 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (5 trials) and "Fallopian Tube Mucinous Adenocarcinoma" (5 trials). Many other conditions were trialed in "New Hanover Regional Medical Center/Zimmer Cancer Center" in a lesser frequency.

Most popular intervention types in "New Hanover Regional Medical Center/Zimmer Cancer Center" are "Drug" (42 trials), "Radiation" (19 trials), "Other" (18 trials), "Procedure" (9 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (10 trials), "Paclitaxel" (8 trials), "Quality-of-Life Assessment" (8 trials), "radiation therapy" (8 trials) and "Questionnaire Administration" (7 trials). Other intervention names were less common.

The vast majority of trials in "New Hanover Regional Medical Center/Zimmer Cancer Center" are 26 trials for "All" genders, 22 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "New Hanover Regional Medical Center/Zimmer Cancer Center". undefined are not yet recruiting, undefined are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in New Hanover Regional Medical Center/Zimmer Cancer Center, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in New Hanover Regional Medical Center/Zimmer Cancer Center, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".